| 000 | 01726 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512005150.0 | ||
| 264 | 0 | _c19891012 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/0049-3848(89)90210-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVogel, G M | |
| 245 | 0 | 0 |
_aComparison of two experimental thrombosis models in rats effects of four glycosaminoglycans. _h[electronic resource] |
| 260 |
_bThrombosis research _cJun 1989 |
||
| 300 |
_a399-410 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aArteriovenous Shunt, Surgical |
| 650 | 0 | 4 |
_aAspirin _xpharmacology |
| 650 | 0 | 4 | _aBlood Coagulation Factors |
| 650 | 0 | 4 |
_aBlood Platelets _ximmunology |
| 650 | 0 | 4 | _aChondroitin Sulfates |
| 650 | 0 | 4 |
_aCoumarins _xtherapeutic use |
| 650 | 0 | 4 | _aDermatan Sulfate |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFibrin _xmetabolism |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
| 650 | 0 | 4 |
_aGlycosaminoglycans _xpharmacology |
| 650 | 0 | 4 |
_aHeparin _xpharmacology |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xpharmacology |
| 650 | 0 | 4 | _aHeparitin Sulfate |
| 650 | 0 | 4 |
_aImmune Sera _xpharmacology |
| 650 | 0 | 4 | _aLigation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligosaccharides _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 | _aVenae Cavae |
| 650 | 0 | 4 |
_aVitamin K _xantagonists & inhibitors |
| 700 | 1 | _aMeuleman, D G | |
| 700 | 1 | _aBourgondiën, F G | |
| 700 | 1 | _aHobbelen, P M | |
| 773 | 0 |
_tThrombosis research _gvol. 54 _gno. 5 _gp. 399-410 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0049-3848(89)90210-7 _zAvailable from publisher's website |
| 999 |
_c2555610 _d2555610 |
||